The authors report a significant increase in dyscontrol in patients with borderline personality disorder who were taking alprazolam during a double-blind, placebo-controlled crossover study. They suggest that caution be used in prescribing alprazolam to patients with similar histories.
Stored only when both papers are in the corpus — 209 citations exist upstream.
Imported from OpenAlex (CC0) — nothing here is generated.